Novo Nordisk A S NVO
NYSE NVO
$46.18 -0.29 (-0.62%)
At close: Aug 20, 2026 · 4:00 PM EDT

Novo Nordisk A S (NVO) Research & Development (2012 - 2016)

Novo Nordisk A S's (NVO) quarterly Research & Development came in at $505.0 million in Q2 2016, up 12.72% YoY from $448.0 million in Q3 2015, and up 3.48% on a QoQ basis from $488.0 million in Q1 2016.

Novo Nordisk A S (NVO) Research & Development (2012 - 2016) Analysis & Trends

Novo Nordisk A S (NVO) has 5 years of Research & Development data on file, last reported at $505.0 million in Q2 2016.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2016 505.00 Mn
Mar 31, 2016 488.00 Mn
Dec 31, 2015 593.00 Mn
Sep 30, 2015 491.00 Mn
Jun 30, 2015 448.00 Mn
Mar 31, 2015 491.00 Mn
Dec 31, 2014 652.00 Mn
Sep 30, 2014 651.00 Mn
Jun 30, 2014 566.00 Mn
Mar 31, 2014 581.00 Mn
Dec 31, 2013 646.00 Mn
Sep 30, 2013 497.00 Mn
Jun 30, 2013 476.00 Mn
Mar 31, 2013 470.00 Mn
Dec 31, 2012 557.00 Mn
Sep 30, 2012 440.00 Mn
Jun 30, 2012 442.00 Mn
Mar 31, 2012 442.00 Mn